Corbus Pharmaceuticals Holdings, Inc. (CRBP) Live Share Price, Invest From India

Corbus Pharmaceuticals Holdings, Inc. Stock Performance

as on November 25, 2025 at 2:29 am IST

Day's Low
Day's High
$11.37
Day's Price Range
$11.94
$11.46
0.79%
Downside
4.19%
Upside
52 Week's Low
52 Week's High
$4.64
52-Week Price Range
$20.56
$11.46
59.51%
Downside
79.41%
Upside

Corbus Pharmaceuticals Holdings, Inc. share price movements today

Previous Close: $12.01
Open: $11.90
Volume: 712.0K
Day's Low - High: $11.37 - $11.94
52 Week Low - High: $4.64 - $20.56

Corbus Pharmaceuticals Holdings, Inc. Historical Returns

1 Month Return: -32.23 %
3 Month Return: + 15.67 %
1 Year Return: -36.27 %
3 Year Return: + 231.59 %
5 Year Return: -68.22 %

Corbus Pharmaceuticals Holdings, Inc. Stock Fundamentals & Key Indicators

Check Corbus Pharmaceuticals Holdings, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$210.8M

EPS (TTM)

-6.696

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-15.31

Industry PE ratio

-2.489044943820225

PEG Ratio

EBITDA

-75.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-55.65%

Corbus Pharmaceuticals Holdings, Inc. Stock Valuation

Track how Corbus Pharmaceuticals Holdings, Inc. P/E has moved over time to understand its valuation trends.

Corbus Pharmaceuticals Holdings, Inc. in the last 5 years

Overview
Trends

Lowest (-10.91x)

September 30, 2024

Today (-15.31x)

November 25, 2025

Industry (-2.49x)

November 25, 2025

Highest (-0.36x)

March 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -15.31x

Corbus Pharmaceuticals Holdings, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corbus Pharmaceuticals Holdings, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Corbus Pharmaceuticals Holdings, Inc.	BUY	$210.8M	-68.22%	-15.31	0.00%
Insmed Incorporated	BUY	$44.1B	436.37%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$57.7B	246.14%	1407.68	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$109.4B	94.41%	30.03	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$80.1B	49.8%	18.11	32.13%

Stock Returns calculator for Corbus Pharmaceuticals Holdings, Inc. Stock including INR - Dollar returns

The Corbus Pharmaceuticals Holdings, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Corbus Pharmaceuticals Holdings, Inc. investment value today

Current value as on today

₹69,636

Returns

₹30,364

(-30.36%)

Returns from Corbus Pharmaceuticals Holdings, Inc. Stock

₹36,156 (-36.16%)

Dollar Returns*

₹5,792 (+5.79%)

Analyst Recommendation on Corbus Pharmaceuticals Holdings, Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Corbus Pharmaceuticals Holdings, Inc.. Average target price of $42.33

Corbus Pharmaceuticals Holdings, Inc. Share Price Target

Get share price movements and forecasts by analysts on Corbus Pharmaceuticals Holdings, Inc..

What analysts predicted

72.93%UPSIDE

Target Price

$42.33

Current Price

$11.46

Analyzed by

8 Analysts

Target

$42.33

Corbus Pharmaceuticals Holdings, Inc. target price $42.33, a slight upside of 72.93% compared to current price of $11.46. According to 8 analysts rating.

Corbus Pharmaceuticals Holdings, Inc. Stock’s Investor Sentiment and Interest

Search interest for Corbus Pharmaceuticals Holdings, Inc. Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 26, 2025 to November 25, 2025

Change:-38% versus previous 30 day period

Corbus Pharmaceuticals Holdings, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	1	-	-	-	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	-15	0	-
Operating Income	-8	-9	-10	-9	-10	-15	-12	-19	-19	-24
EBITDA	-7	-8	-7	-5	-9	-13	-9	-18	-17	-23
Interest Expense	1	0	0	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-10	-8	-6	-9	-13	-9	-16	-17	-23
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	-8	-10	-8	-6	-9	-13	-9	-16	-17	-23
Net Profit Margin	0.00%	0.00%	-594.27%	0.00%	0.00%	0.00%	-1354.89%	0.00%	0.00%	0.00%

Corbus Pharmaceuticals Holdings, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	1	2	4	36	3	0	-	-	-
Gross Profit	-5	-13	-23	-43	-53	3	0	-1	-31	0
Operating Income	-8	-19	-32	-56	-77	-122	-55	-34	-45	-48
EBITDA	-8	-19	-32	-56	-76	-121	-54	-38	-40	-37
Interest Expense	0	-	0	-	0	1	1	2	2	1
Depreciation	-	-	0	0	1	1	1	1	1	0
Income Before Tax	-8	-19	-32	-55	-71	-111	-45	-42	-44	-40
Income Tax Expense	0	0	0	1	-2	0	0	13	-	-
Net Income	-8	-19	-32	-55	-71	-111	-45	-55	-44	-40
Net Profit Margin	-1365.05%	-1046.27%	-1328.65%	-1154.48%	-197.69%	-2826.08%	-5166.42%	0.00%	0.00%	0.00%

Corbus Pharmaceuticals Holdings, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-10	-8	-6	-9	-13	-9	-16	-17	-23
Operating Cash Flow	-7	-6	-7	-8	-13	-10	-16	-16	-15
Investing Cash Flow	10	10	-98	-16	-15	8	18	17	19
Financing Cash Flow	0	-1	106	34	25	0	-	-	2
Change in Cash	2	2	0	9	-4	-2	1	1	6

Corbus Pharmaceuticals Holdings, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-19	-32	-55	-71	-111	-45	-42	-44	-40
Operating Cash Flow	-13	-27	-30	-45	-99	-48	-37	-36	-41
Investing Cash Flow	0	0	-2	-2	0	-73	30	35	-121
Financing Cash Flow	16	76	11	38	154	60	0	-2	166
Change in Cash	2	47	-20	-9	54	-60	-8	-3	3

Global Institutional Holdings in Corbus Pharmaceuticals Holdings, Inc.

Funds	Holdings
Cormorant Asset Management, LLC	19.38%
Orbimed Advisors, LLC	9.57%
Octagon Capital Advisors LP	9.1%
Vanguard Group Inc	4.89%
Prosight Management, LP	4.73%

See all

Insights on Corbus Pharmaceuticals Holdings, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 years, CRBP stock has moved up by 248.1%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 168.3% return, outperforming this stock by 201.4%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 979.6% return, outperforming this stock by 731.5%

About Corbus Pharmaceuticals Holdings, Inc.

corbus pharmaceuticals holdings, inc. (nasdaq: crbp) is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs. the company's lead product candidate, resunab™, is a first-in-class, oral anti-inflammatory drug that acts to resolve inflammation through an endogenous pathway. resunab is scheduled to commence three phase 2 clinical trials in 2015 for the treatment of cystic fibrosis, diffuse systemic sclerosis ("scleroderma") and dermatomyositis, three diseases in which inflammation contributes to disease progression. resunab also has the potential to treat additional rare, inflammatory diseases.

Organisation	Corbus Pharmaceuticals Holdings, Inc.
Headquarters	500 River Ridge Drive, Norwood, MA, United States, 02062
Industry	Health Technology
CEO	Dr. Yuval Cohen Ph.D.
E-voting on shares	Click here to vote

Key Management of Corbus Pharmaceuticals Holdings, Inc.

Name	Title
Ms. Christina Bertsch M.A.	Vice President of Human Resources
Dr. Yuval Cohen Ph.D.	CEO & Director
Mr. Sean F. Moran CPA, M.B.A.	Chief Financial Officer
Dr. Dominic Smethurst M.A., M.D.	Chief Medical Officer
Dr. Ian Hodgson B.Sc., Ph.D.	Chief Operating Officer
Mr. G. Scott Goeken J.D., M.S.	General Counsel & Corporate Secretary

FAQs

What is Corbus Pharmaceuticals Holdings, Inc. share price today?

Corbus Pharmaceuticals Holdings, Inc. share price today is $11.46 as on November 25, 2025 at 2:29 am IST at the close of the market. Corbus Pharmaceuticals Holdings, Inc. share today touched a day high of $11.94 and a low of $11.37.

What is the 52 week high and 52 week low for Corbus Pharmaceuticals Holdings, Inc. share?

Corbus Pharmaceuticals Holdings, Inc. share touched a 52 week high of $20.56 on October 20, 2025 and a 52 week low of $4.64 on April 7, 2025. Corbus Pharmaceuticals Holdings, Inc. stock price today i.e. November 25, 2025 at 2:29 am IST is closed at $11.46,which is 44.26% down from its 52 week high and 146.98% up from its 52 week low.

What is Corbus Pharmaceuticals Holdings, Inc.'s market capitalisation today?

Corbus Pharmaceuticals Holdings, Inc. market capitalisation is $0.00T as on November 25, 2025 at 2:29 am IST.

How to invest in Corbus Pharmaceuticals Holdings, Inc. Stock (CRBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Corbus Pharmaceuticals Holdings, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corbus Pharmaceuticals Holdings, Inc. Shares that will get you 0.1309 shares as per Corbus Pharmaceuticals Holdings, Inc. share price of $11.46 per share as on November 25, 2025 at 2:29 am IST.

What is the minimum amount required to buy Corbus Pharmaceuticals Holdings, Inc. Stock (CRBP) from India?

Indian investors can start investing in Corbus Pharmaceuticals Holdings, Inc. (CRBP) shares with as little as ₹89.151 or $1 (as of November 25, 2025 at 10:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹891.51 in Corbus Pharmaceuticals Holdings, Inc. stock (as per the Rupee-Dollar exchange rate as on November 25, 2025 at 10:38 am IST). Based on Corbus Pharmaceuticals Holdings, Inc. share’s latest price of $11.46 as on November 25, 2025 at 2:29 am IST, you will get 0.8726 shares of Corbus Pharmaceuticals Holdings, Inc.. Learn more about fractional shares .

What are the returns that Corbus Pharmaceuticals Holdings, Inc. has given to Indian investors in the last 5 years?

Corbus Pharmaceuticals Holdings, Inc. stock has given -68.22% share price returns and 21.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?